West Pharmaceutical Services, I Price Today
West Pharmaceutical Services, I
WST
Healthcare
$27.85B
💰
Market Cap
51.5
💸
Price to Earnings
$7.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
5 |
Strong Buy |
4 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
WST Price Forecast Target
375.1 👉 420.0 +12%
WST EPS Forecast
7.3 👉 8.8 +21%
Financials
Profit Margin
18 %
Revenue Growth
-2.3 %
Dividend
$ 0.76
Held Percent
0.5% - Insiders
96.2% - Institutions
3.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $3.1B
-
💰 Blackrock Inc. $2.8B
-
💰 Bank Of New York Mellon Corporation $1.3B
-
💰 State Street Corporation $1.1B
-
💰 Price (T.Rowe) Associates Inc $984.9M
Stock Ideas
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…📮FAQ
Some Frequently Asked Questions.
The West Pharmaceutical Services, I industry is Medical Instruments & Supplies
The West Pharmaceutical Services, I sector is Healthcare
The West Pharmaceutical Services, I forecasted predicted Price to Earnings PE ratio is 42.5
The West Pharmaceutical Services, I Price to Earnings PE ratio is 51.5
The Market Capitalization of West Pharmaceutical Services, I is $27.85B
There are total of 73457930 float shares with 96.2% held by Institutions and 0.5% held by insiders
The MWest Pharmaceutical Services, I forecasted Earnings per Share EPS is $8.8
The West Pharmaceutical Services, I Earnings per Share EPS is 7.3
The West Pharmaceutical Services, I company has $1136200000 gross profits with 18 profit margins
The West Pharmaceutical Services, I Earnings Growth is -0.169% with -0.177% quarterly earnings growth
The West Pharmaceutical Services, I Revenue is $2865999872 with -0.023 revenue growth
The price target for West Pharmaceutical Services, I stock is $420.0 for the high target and $325.0 for the low target
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, with the following breakdown:
- Buy: 5
- Strong Buy: 4
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of West Pharmaceutical Services, I is 1.1
The dividend of West Pharmaceutical Services, I is $0.76
The dividend yield of West Pharmaceutical Services, I is 0.002%
The biggest institutional and mutual fund holders of West Pharmaceutical Services, I stock are
- Vanguard Group Inc
- Blackrock Inc.
- Bank Of New York Mellon Corporation
- State Street Corporation
The West Pharmaceutical Services, I ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0